FDA 483 - Marcus Research Laboratory, Inc. - July 12, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Marcus Research Laboratory, Inc. in St. Louis, MO, revealed significant deficiencies in equipment construction, design, and cleaning validation for their Povidone-Iodine drug substance manufacturing. Inspectors noted that stainless steel equipment surfaces appeared reactive with the iodine API, potentially forming toxic metal iodides. The firm also lacked adequate procedures for equipment design and cleaning validation, failing to properly assess impurity risks and validate cleaning methods for non-uniform surfaces.
ID · f45a740c-8cea-4297-a692-6a649360152d